1. Global incidence of young‐onset dementia: A systematic review and meta‐analysis
- Author
-
Hendriks, Stevie, Peetoom, Kirsten, Bakker, Christian, Koopmans, Raymond, van der Flier, Wiesje, Papma, Janne, Verhey, Frans, de Vugt, Marjolein, Köhler, Sebastian, Neurology, and Amsterdam Neuroscience - Neurodegeneration
- Subjects
RISK ,Epidemiology ,Health Policy ,INCIDENCE RATES ,REPORTED SLEEP DISTURBANCE ,worldwide ,TRENDS ,PREVALENCE ,TIME ,meta-analysis ,ALZHEIMERS-DISEASE ,Psychiatry and Mental health ,Cellular and Molecular Neuroscience ,PRESENILE-DEMENTIA ,SDG 3 - Good Health and Well-being ,Developmental Neuroscience ,incidence ,young-onset dementia ,Neurology (clinical) ,Geriatrics and Gerontology ,POPULATION - Abstract
Introduction: Reliable data on the incidence rates for young-onset dementia (YOD) are lacking, but are necessary for research on disease etiology and to raise awareness among health care professionals. Methods: We performed a systematic review and meta-analysis on population-based studies on the incidence of YOD, published between January 1, 1990 and February 1, 2022, according to Meta-analyses of Observational Studies in Epidemiology (MOOSE) guidelines. Data were analyzed using random-effects meta-analyses. Results were age-standardized, and heterogeneity was assessed by subgroup analyses and meta-regression. Results: Sixty-one articles were included. Global age-standardized incidence rates increased from 0.17/100,000 in age 30 to 34 years, to 5.14/100,000 in age 60 to 64 years, giving a global total age-standardized incidence rate of 11 per 100,000 in age 30 to 64. This corresponds to 370,000 new YOD cases annually worldwide. Heterogeneity was high and meta-regression showed geographic location significantly influenced this heterogeneity. Discussion: This meta-analysis shows the current best estimate of YOD incidence. New prospective cohort studies are needed.
- Published
- 2022